Pharmacokinetics and antibacterial activity of daily gentamicin.

H Skopnik, R Wallraf, B Nies, K Tröster, G Heimann

Kinderklinik der RWTH Aachen, Federal Republic of Germany.

Twenty full term neonates with suspected bacterial infection were randomly assigned to a once daily or a twice daily dosage regimen with gentamicin (4 mg/kg/day). Concomitantly all patients were treated with ampicillin (200 mg/kg/day). The gentamicin concentration time curves were analysed by an open two compartment model under steady state conditions on day 4 of treatment. The mean theoretical maximum serum concentration in the group taking gentamicin once daily (10.9 micrograms/ml) was significantly higher than in the group taking it twice daily (7.4 micrograms/ml). Potentially toxic serum concentrations were never reached. Mean trough concentrations were comparable in both groups (once daily 0.8 micrograms/ml; twice daily 1.0 micrograms/ml). Urinary alanine aminopeptidase excretion increased during and even two days after end of treatment in both groups without any significant differences. The results of the dynamic in vitro model revealed that both dosage schedules showed comparable bactericidal effects on pathogens inhibited by low concentrations of gentamicin like Escherichia coli and Staphylococcus aureus. However the once daily regimen was significantly superior in isolates with high minimal inhibitory concentrations.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hale, L. S., Durham, C. R. (2005). A simple, weight-based, extended-interval gentamicin dosage protocol for neonates. Am J Health Syst Pharm 62: 1613-1616 [Full Text]  
• Nestaas, E, Bangstad, H-J, Sandvik, L, Wathne, K-O (2005). Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch. Dis. Child. Fetal Neonatal Ed. 90: F294-f300 [Abstract] [Full Text]  
• Lanao, J. M., Calvo, M. V., Mesa, J. A., Martin-Suarez, A., Carbajosa, M. T., Miguelez, F., Dominguez-Gil, A. (2004). Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. J Antimicrob Chemother 54: 193-198 [Abstract] [Full Text]  
• English, M, Mohammed, S, Ross, A, Ndirangu, S, Kokwaro, G, Shann, F, Marsh, K (2004). A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants. Arch. Dis. Child. 89: 665-669 [Abstract] [Full Text]  
• Treluyer, J. M., Merle, Y., Tonnelier, S., Rey, E., Pons, G. (2002). Nonparametric Population Pharmacokinetic Analysis of Amikacin in Neonates, Infants, and Children. Antimicrob. Agents Chemother. 46: 1381-1387 [Abstract] [Full Text]  
• Lundergan, F. S., Kim, E. H., Cohen, R. S. (1999). Once-daily Gentamicin Dosing in Newborn Infants. Pediatrics 103: 1228-1234 [Abstract] [Full Text]